Vigil Neuroscience (VIGL) Competitors $8.05 -0.02 (-0.25%) Closing price 04:00 PM EasternExtended Trading$8.06 +0.01 (+0.19%) As of 04:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock VIGL vs. NVTS, VERA, TVTX, EWTX, EVO, BHVN, MESO, ANIP, HROW, and PAHCShould you be buying Vigil Neuroscience stock or one of its competitors? The main competitors of Vigil Neuroscience include Navitas Semiconductor (NVTS), Vera Therapeutics (VERA), Travere Therapeutics (TVTX), Edgewise Therapeutics (EWTX), Evotec (EVO), Biohaven (BHVN), Mesoblast (MESO), ANI Pharmaceuticals (ANIP), Harrow (HROW), and Phibro Animal Health (PAHC). Vigil Neuroscience vs. Its Competitors Navitas Semiconductor Vera Therapeutics Travere Therapeutics Edgewise Therapeutics Evotec Biohaven Mesoblast ANI Pharmaceuticals Harrow Phibro Animal Health Vigil Neuroscience (NASDAQ:VIGL) and Navitas Semiconductor (NASDAQ:NVTS) are related small-cap companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, valuation, earnings, profitability, media sentiment and analyst recommendations. Is VIGL or NVTS more profitable? Vigil Neuroscience has a net margin of 0.00% compared to Navitas Semiconductor's net margin of -131.83%. Navitas Semiconductor's return on equity of -22.62% beat Vigil Neuroscience's return on equity.Company Net Margins Return on Equity Return on Assets Vigil NeuroscienceN/A -111.70% -74.67% Navitas Semiconductor -131.83%-22.62%-20.38% Does the media refer more to VIGL or NVTS? In the previous week, Navitas Semiconductor had 13 more articles in the media than Vigil Neuroscience. MarketBeat recorded 13 mentions for Navitas Semiconductor and 0 mentions for Vigil Neuroscience. Navitas Semiconductor's average media sentiment score of 0.62 beat Vigil Neuroscience's score of 0.00 indicating that Navitas Semiconductor is being referred to more favorably in the news media. Company Overall Sentiment Vigil Neuroscience Neutral Navitas Semiconductor Positive Do analysts prefer VIGL or NVTS? Vigil Neuroscience presently has a consensus target price of $10.80, indicating a potential upside of 34.16%. Navitas Semiconductor has a consensus target price of $3.71, indicating a potential downside of 58.70%. Given Vigil Neuroscience's higher possible upside, analysts plainly believe Vigil Neuroscience is more favorable than Navitas Semiconductor.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vigil Neuroscience 0 Sell rating(s) 10 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Navitas Semiconductor 1 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.50 Do insiders and institutionals believe in VIGL or NVTS? 83.6% of Vigil Neuroscience shares are owned by institutional investors. Comparatively, 46.1% of Navitas Semiconductor shares are owned by institutional investors. 18.0% of Vigil Neuroscience shares are owned by insiders. Comparatively, 29.9% of Navitas Semiconductor shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Which has stronger earnings and valuation, VIGL or NVTS? Vigil Neuroscience has higher earnings, but lower revenue than Navitas Semiconductor. Navitas Semiconductor is trading at a lower price-to-earnings ratio than Vigil Neuroscience, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVigil NeuroscienceN/AN/A-$84.26M-$2.05-3.93Navitas Semiconductor$83.30M20.68-$84.60M-$0.52-17.27 Which has more risk and volatility, VIGL or NVTS? Vigil Neuroscience has a beta of 3.34, indicating that its share price is 234% more volatile than the S&P 500. Comparatively, Navitas Semiconductor has a beta of 3.01, indicating that its share price is 201% more volatile than the S&P 500. SummaryNavitas Semiconductor beats Vigil Neuroscience on 9 of the 15 factors compared between the two stocks. Get Vigil Neuroscience News Delivered to You Automatically Sign up to receive the latest news and ratings for VIGL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VIGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VIGL vs. The Competition Export to ExcelMetricVigil NeuroscienceMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$383.91M$3.06B$5.67B$9.50BDividend YieldN/A2.44%4.05%4.00%P/E Ratio-3.9320.9027.9219.98Price / SalesN/A245.97397.1882.73Price / CashN/A41.9636.1958.45Price / Book4.608.288.635.82Net Income-$84.26M-$55.19M$3.24B$258.42M7 Day Performance-0.37%5.09%3.17%1.94%1 Month Performance1.51%17.64%10.73%12.08%1 Year Performance89.41%7.03%35.04%20.90% Vigil Neuroscience Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VIGLVigil Neuroscience3.4038 of 5 stars$8.05-0.2%$10.80+34.2%+102.3%$383.91MN/A-3.9340NVTSNavitas Semiconductor1.0671 of 5 stars$5.87+0.5%$3.71-36.8%+112.0%$1.13B$74.15M-11.29160Options VolumeVERAVera Therapeutics4.2391 of 5 stars$23.78-0.2%$65.00+173.3%-35.5%$1.52BN/A-7.9340TVTXTravere Therapeutics2.9838 of 5 stars$16.91+2.7%$32.14+90.1%+64.9%$1.50B$233.18M-6.02460Positive NewsUpcoming EarningsEWTXEdgewise Therapeutics1.7189 of 5 stars$13.93+0.7%$40.00+187.2%-33.9%$1.47BN/A-8.9960EVOEvotec2.079 of 5 stars$4.12+1.2%$5.93+44.0%-20.1%$1.46B$862.40M0.004,827Gap UpBHVNBiohaven2.4144 of 5 stars$14.18+1.8%$58.46+312.2%-63.7%$1.45BN/A-1.52239MESOMesoblast0.9159 of 5 stars$11.17+0.5%$18.00+61.1%+94.6%$1.43B$5.90M0.0080Upcoming EarningsGap UpANIPANI Pharmaceuticals3.771 of 5 stars$65.19+0.4%$78.88+21.0%+3.4%$1.41B$674.07M-51.33600News CoverageHROWHarrow2.5949 of 5 stars$35.62+2.0%$63.83+79.2%+50.9%$1.31B$199.61M-63.61180PAHCPhibro Animal Health4.069 of 5 stars$31.54+2.4%$24.40-22.6%+57.5%$1.28B$1.02B40.441,940Positive News Related Companies and Tools Related Companies NVTS Competitors VERA Competitors TVTX Competitors EWTX Competitors EVO Competitors BHVN Competitors MESO Competitors ANIP Competitors HROW Competitors PAHC Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VIGL) was last updated on 7/24/2025 by MarketBeat.com Staff From Our PartnersA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredElon Just Fired the IRS Agents Targeting Your SavingsElon Musk just fired 6,700 IRS agents — and exposed a war on your retirement. While D.C. scrambles to regai...Priority Gold | SponsoredTrump’s $100 Trillion Land Rush Is OnWhat Is "The US: IPO"? You won't hear this on CNBC... but the government may soon open up hundreds of trill...Stansberry Research | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredBREAKING: The House just passed 3 pro-crypto bills!Experts Believe Altcoin Season is Here! With this new legislation in effect, crypto experts across the coun...Crypto 101 Media | SponsoredWhy Elon put $51 million into thisA single U.S. company has started producing a “miracle metal” once locked in research labs. Now? They’re qu...True Market Insiders | SponsoredFREE GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...GoldCo Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vigil Neuroscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vigil Neuroscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
